Invesco NASDAQ Biotechnology ETF
IBBQ
13 hedge funds and large institutions have $7.23M invested in Invesco NASDAQ Biotechnology ETF in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 3 closing their positions.
600% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 1
15.15% more ownership
Funds ownership: 38.58% → 53.73% (+15%)
6% less capital invested
Capital invested by funds: $7.73M → $7.23M (-$500K)
7% less funds holding
Funds holding: 14 → 13 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$321K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$54.9K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$30.1K |
| 4 |
WWP
WR Wealth Planners
Columbia,
Missouri
|
+$14.4K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$12.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBP
Banco BTG Pactual
Rio De Janeiro,
Brazil
|
-$786K |
| 2 |
CIAS
Capital Investment Advisory Services
Raleigh,
North Carolina
|
-$13.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$9.49K |
| 4 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
-$3.76K |
IBBQ Hedge Fund Activity: Q1 2023 in Review
13 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Invesco NASDAQ Biotechnology ETF (IBBQ) for Q1 2023, worth a combined $7.23M — down 6.5% from $7.73M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of IBBQ and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 7 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $321K. The largest seller was Banco BTG Pactual, exiting entirely with an estimated $786K sold.
- 13 institutional investors held Invesco NASDAQ Biotechnology ETF (IBBQ) as of Q1 2023, down from 14 in Q4 2022.
- Funds reported $7.23M of Invesco NASDAQ Biotechnology ETF stock for Q1 2023, down 6.5% quarter-over-quarter.
- 2 funds opened new Invesco NASDAQ Biotechnology ETF positions in Q1 2023 and 3 closed out, a net change of -1 holder.
- The largest Invesco NASDAQ Biotechnology ETF buyer in Q1 2023 was Citadel Advisors, an estimated $321K added.
- The largest Invesco NASDAQ Biotechnology ETF seller in Q1 2023 was Banco BTG Pactual, an estimated $786K sold.
Based on aggregated 13F filings for Q1 2023.